Roche's new diagnostic test arrives to detect Covid variants.
The Swiss pharmaceutical group Roche announced today the launch of a new diagnostic test, designed to detect variations of the coronavirus. This new test should help scientists monitor mutations of the virus, their prevalence and potential impact on the diagnosis of infections, vaccines and therapies, the Swiss group said in a statement. Called CobasSARS-CoV-2 Variant Set 1, this test allows to detect and differentiate the different mutations observed in the English, South African and Brazilian variants.
YOU MAY ALSO BE INTERESTED IN: Naples: in a coma after the Astrazeneca vaccine, 'Pray for my sister, help us'
“Continuous surveillance is essential for public health,” said Thomas Schinecker, director of Roche’s Diagnostics division, quoted in the press release. Red-Sim
EDITORIAL TEAM
Choose the social channel you want to subscribe to